Greenhushing: What It Is & Why It Matters
Podcast - Navigating Regulatory Challenges in M&A Transactions
The Demystification of Employee Retention Credits for Private Equity Deals — PE Pathways Podcast
OG Talks: Good Energy and Navigating Transactions
Troutman Pepper Locke - The Powerhouse Merger – The Consumer Finance Podcast
SBA’s Final Rule Is Here: Key Takeaways on Updates to HUBZone Program, Other Small Business Programs, and Various Small Business Matters
Navigating Restrictive Covenants in Private Equity — PE Pathways Podcast
Executive Compensation in Mergers and Acquisitions — Troutman Pepper Podcast
Private M&A 2024: Key Trends and Forecasts
M&A Considerations for Serial Acquirers
Fierce Competition Podcast | Below-Threshold Mergers: Global Antitrust Scrutiny
Best Practices for Preparing Your Company for Exit
JONES DAY TALKS®: Five Pillars of Series A Shareholder Rights: A Discussion for VC Investors
What is Reverse Vesting and What are the Tax Considerations?
What Does "Cash Free / Debt Free" Mean?
How is Purchase Price Established?
What's the Best Transaction Structure for My Sale?
Should You Engage a Financial Advisor?
Implementing IP Best Practices to Maximize Exit Value
What's the Timeline for a Sale Process?
In 2024, the Biden Administration substantially expanded executive branch power to monitor foreign investment into and out of the United States. First, the administration continued efforts to aggressively police compliance...more
Continued AI innovation, pent-up cash balances, and the potential for renewed investor optimism and increased regulatory clarity will likely drive dealmaking later this year, after the bout of market uncertainty subsides....more
President Donald Trump’s early executive orders have not specifically called out antitrust enforcement, but several impact antitrust agencies and could influence antitrust policy and enforcement over the next four years. ...more
Our M&A team is honored to have represented clients in some of the most compelling transactions in 2024, from advising the iconic rock band KISS and its co-founders Gene Simmons and Paul Stanley in the sale of all assets...more
Medtech mergers and acquisitions (M&A) and venture capital (VC) showed signs of life in 2024, contributing to an overall optimistic outlook for the sector this year despite lingering headwinds. Strategic investments are...more
President Donald Trump has taken office, and organizations can stay ahead of US policy changes and strategic shifts that may impact operations under the new presidential administration. McDermott’s cross-practice team, along...more
DTC Telehealth Platforms - Arrangements involving telemedicine and direct-to-consumer (“DTC”) business services are expected to be a source of major regulatory scrutiny. In 2024, such arrangements were the focus of proposed...more
2025 is shaping up to be a busy year in tech. While blustery economic tailwinds continue to drive digital transformation, a new presidential administration promises shifts in policy that will likely keep businesses on their...more
The Trump Administration’s antitrust enforcement priorities are beginning to take shape. On January 20, 2025, President Trump designated former Federal Trade Commission (FTC) commissioner Andrew Ferguson as the agency’s next...more
As we step into a new year, the potential shifts under a second Trump administration loom large. Our 2025 Insights publication analyzes the impacts these changes could have on both U.S. and global business environments,...more
Welcome to the latest edition of our Healthcare & Life Sciences Market Update, in which we explore the evolving landscape of investment trends, regulatory challenges, and strategic opportunities shaping the global market. ...more
Our latest edition explores the top merger control trends across the EU, US, UK, Middle East and Australia, and the outlook for 2025. EU and US merger control enforcement: quo vadis? In the EU, Executive Vice...more
Key Points - - Accelerated M&A activity by financial sponsors is expected in the near term due to improved market conditions and deregulation under the Trump administration. - With the rapid development of new AI use...more
As we kick off 2025, it's worth reflecting on the forces that shaped digital health in 2024. From early-stage innovation capturing investor attention to mega funds like a16z and General Catalyst driving dealmaking, the year...more
A variety of factors are expected to significantly increase Canadian M&A activity in 2025. These include the likelihood of a more merger friendly regulatory environment in the United States for cross-border transactions,...more
The incoming Trump administration is expected to make several policy changes likely to impact tech transactions. President-elect Donald Trump has promised to reduce regulation and cut federal bureaucracy, which he says have...more
Foley & Lardner announced the 2024 installment of its Auto Trends series—A Year in Review: Updates, Trends and the Road Ahead. This series delves deep into the transformative forces shaping the automotive world by providing...more
As the global markets look towards 2025, a dynamic evolution is anticipated within the landscape of mergers and acquisitions (M&A). Key strategic drivers such as regulatory adjustments, monetary policy normalizations, and...more
Our Technology Industry Team thought leaders have pulled together their top predictions for the new year so that employers can get a running start to 2025....more
Welcome to the latest edition of M&A Insights, where we bring together partners from across the A&O Shearman network to explore the themes shaping global dealmaking. The election of Donald Trump as President is expected to...more
In our biannual M&A trends report we explore the possible impact of the new U.S. administration on dealmaking, the dynamics of transatlantic M&A, private equity exits, and Mario Draghi’s proposals to reshape the European...more
At what point has a director served too long? What about term limits? A mandatory retirement age? When do a director’s skills become stale? These issues are addressed in this issue of The Informed Board, as well as why proxy...more
Last month, the U.S. Department of Justice (“DOJ”) quietly updated its March 2023 guidance on the evaluation of corporate compliance programs. Of course, DOJ did not conduct a major rewrite, but interestingly, the updated...more
As geopolitical tensions ratchet higher across the globe – fueled by the ongoing conflict in Ukraine, turbulent relations between China, the United States (US), and Europe, escalating conflict in the Middle East, and...more
On 19 September 2024, we were once again delighted to assemble hundreds of healthcare professionals, investors, and industry changemakers at The Langham in London for our annual Healthcare Private Equity (HPE) Europe...more